The influence of fat intake, estrogen, age, and gender on postprandial lipds and glucose

Gynecology Department,Herning Hospital0 个研究点开始时间: 2015年5月22日最近更新: 2016年10月10日

适应症

试验速览

暂无简介。

•Healthy individuals age 45-55 and 65-80 years of both gender. Only the women age 45-55 are subjected to the estrogen replacement and the intake is randomized to start with either placebo or active substance for these women only. All other groups, i.e. males age 45-55, and both gender age 65-80 act as controls
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 40
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Person suffering form dumping syndorme, hypercholesterolemia, hypertension, abuse of substance or alcohol, known kidney-, liver-, biliary-, cardiovascular and metabolic diseases, thromboembolic disorders, active cancer of the uterus or breast and other hormone therapy.

发起方

Gynecology Department,Herning Hospital